Microbiome as a biomarker and therapeutic target in pancreatic cancerGhazaleh Pourali, Amir Avan, Danial Kazemi et al.|BMC Microbiology|2024Cited by 50
Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospectiveNima Zafari, Amir Avan, Mahla Velayati et al.|Life Sciences|2022Cited by 42
Metabolic Pathways Regulating Colorectal Cancer: A Potential TherapeuticApproachNima Zafari, Amir Avan, Mahla Velayati et al.|Current Pharmaceutical Design|2022Cited by 23
The circadian clock as a potential biomarker and therapeutic target in pancreatic cancerGhazaleh Pourali, Amir Avan, Mahshid Arastonejad et al.|Molecular and Cellular Biochemistry|2023Cited by 18
Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancerFatemeh Khojasteh‐Leylakoohi, Amir Avan, Reza Mohit et al.|Scientific Reports|2023Cited by 17